← Leaderboards
Tamer Sallam
University Of California Los Angeles
$10,795,420
Attributed
$11,040,486
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,040,486 · 6
By mechanism
R01$9,788,809 · 4
K08$884,078 · 1
T32$367,599 · 1
Top collaborators
- Andrea L Hevener1 shared
- Peter J Tontonoz1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Peter J Tontonoz$38,870,418
- Albert Lai$2,387,656
- Chongyuan Luo$9,839,250
- Margaret Goodell$39,279,889
- Yin Tintut$5,945,406
Others in their field
Top investigators on “Liver”
- David Heimbrook · Leidos Biomedical Research, Inc.$183,557,534
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard Douglas Moore · Johns Hopkins University$59,048,354
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Michael S. Saag · University Of Alabama At Birmingham$50,288,385
- Mark A Kay · Stanford University$49,905,067
Research focus
LiverCholesterolRegulationInsightAffectPlayCardiovascular DiseasesMetabolismLipidsGene ExpressionPhysiologicalHomeostasisChromatinGenesMetabolicMolecularBindingCellsSeriesPathway InteractionsMammalian CellGene Expression RegulationAnimalsBiological
Grant awards (26)
RNA binding proteins in atherosclerosis$710,427
R01 · FY2025 · HL · contact PI
RNA modification in cardiometabolic disease$559,709
R01 · FY2025 · DK · contact PI
Interdisciplinary Training Program in Metabolism (UCLA-ITPM)$367,599
T32 · FY2025 · DK
Licensing LncRNAs in Atherosclerosis$614,422
R01 · FY2024 · HL · contact PI
RNA modification in cardiometabolic disease$537,319
R01 · FY2024 · DK · contact PI
Licensing LncRNAs in Atherosclerosis$626,961
R01 · FY2023 · HL · contact PI
RNA modification in cardiometabolic disease$559,709
R01 · FY2023 · DK · contact PI
Licensing LncRNAs in Atherosclerosis$626,961
R01 · FY2022 · HL · contact PI
RNA modification in cardiometabolic disease$559,709
R01 · FY2022 · DK · contact PI
Long Non-coding RNAs in the Regulation of Adipogenesis and Obesity$380,790
R01 · FY2022 · DK · contact PI
RNA-binding proteins in atherosclerosis$380,340
R01 · FY2022 · HL · contact PI
Licensing LncRNAs in Atherosclerosis$626,961
R01 · FY2021 · HL · contact PI
RNA modification in cardiometabolic disease$559,709
R01 · FY2021 · DK · contact PI
Long Non-coding RNAs in the Regulation of Adipogenesis and Obesity$380,790
R01 · FY2021 · DK · contact PI
RNA-binding proteins in atherosclerosis$380,529
R01 · FY2021 · HL · contact PI
Long Non-coding RNAs in the Regulation of Adipogenesis and Obesity$380,790
R01 · FY2020 · DK · contact PI
RNA-binding proteins in atherosclerosis$380,715
R01 · FY2020 · HL · contact PI
RNA-binding proteins in atherosclerosis$380,897
R01 · FY2019 · HL · contact PI
Long Non-coding RNAs in the Regulation of Adipogenesis and Obesity$380,790
R01 · FY2019 · DK · contact PI
Long Non-coding RNAs in Cardiometabolic Disease$184,907
K08 · FY2019 · HL · contact PI
Long Non-coding RNAs in the Regulation of Adipogenesis and Obesity$380,790
R01 · FY2018 · DK · contact PI
RNA-binding proteins in atherosclerosis$380,491
R01 · FY2018 · HL · contact PI
Long Non-coding RNAs in Cardiometabolic Disease$184,907
K08 · FY2018 · HL · contact PI
Long Non-coding RNAs in Cardiometabolic Disease$184,907
K08 · FY2017 · HL · contact PI
Long Non-coding RNAs in Cardiometabolic Disease$184,907
K08 · FY2016 · HL · contact PI
Long Non-coding RNAs in Cardiometabolic Disease$144,450
K08 · FY2015 · HL · contact PI